Skip to the reading
Tirzepatide CareA field handbook

Coverage and payment

Which payment route applies to this plan

Give the insurer the exact product and the reason for treatment, then ask what happens next.

Ask about the proposed product

Ask whether your plan covers the named medicine for the condition being treated. Ask for your cost through the plan, rather than a general price for the drug. Request a written answer or a reference for the conversation.

Ask which medicines appear on the plan’s coverage list, also called its formulary. If it requires prior authorization, payment needs the plan’s approval before the pharmacy can supply the drug.

An approved medical use still leaves the plan’s approval process and medicine list to check. Coverage is possible, rather than assured.

Ordinary Medicare drug coverage

As checked in September 2026, the basic Medicare Part D drug benefit did not pay for treatment used only for weight loss.

It may pay when the medicine treats another accepted medical problem, subject to the plan’s terms.

Treatment of type 2 diabetes with Mounjaro can qualify. Zepbound can qualify for an adult who has both obesity and obstructive sleep apnea of moderate or severe degree. With this kind of sleep apnea, blocked airflow causes repeated breaks in breathing during sleep.

Ask the plan which route it is assessing. A refusal under one route does not explain what another route requires.

The temporary Medicare Bridge

Medicare’s temporary GLP-1 Bridge gives another payment route for some medicines used for weight loss. Its September 2026 rules set the patient charge at $50 per monthly supply, for those who qualify.

The recorded dates are 1 July 2026 to 31 December 2027. Pharmacy payments under the Bridge use a system separate from the usual Medicare Part D drug benefit. A central service handles those payments and approval requests in 2026.

For tirzepatide, the Bridge’s September 2026 product list includes only the Zepbound KwikPen, not its vials or single-dose pens.

The September 2026 Bridge rules start with age: at least 18. Drug coverage must come from a qualifying Medicare plan. A stand-alone plan for Part D can qualify. Medicare Advantage drug coverage must be part of a plan that coordinates care. Have the insurer confirm that yours is one of these plan types.

The weight test uses body mass index, shortened to BMI, which compares weight with height. With BMI of at least 35, no other listed health problem is needed for this test.

With BMI of at least 30, a listed heart, blood-pressure or kidney problem is also needed. One is heart failure of the type doctors call preserved ejection fraction; ask your doctor whether that is the diagnosis in your records. Another is blood pressure that remains too high while taking two medicines to lower it. With those medicines in use, a bottom number over 90 meets the rule, as does a top number over 140. Kidney disease also qualifies at stage 3a or a more advanced stage; ask the prescriber to check the stage in your records.

With BMI of at least 27, the listed health problems are different. These are pre-diabetes; artery disease in the limbs with symptoms; having had a stroke; or having had a heart attack. Ask the prescriber to match your records to this list.

Type 2 diabetes sends the coverage request to ordinary Part D, rather than to this programme. Obstructive sleep apnea of moderate or severe degree follows that route too. There is also a specific liver-disease exclusion; ask the prescriber to check the precise diagnosis and scarring in your records. Prescribing to lower major heart or stroke risks is another Part D route. A GLP-1 drug already received through Part D during 2026 rules out Bridge access for that year. As of September 2026, the corresponding rule for past use in 2027 was still unset.

Access also requires a prescription, with approval arranged in advance. The Bridge terms pair the medicine with ongoing changes to food choices and physical activity.

Each $50 payment stays separate from your ordinary Part D spending. It buys no progress towards that benefit’s yearly limit on your own drug costs. You do not have to meet Part D’s deductible, its initial amount to pay, to use the Bridge. Help based on a low income does not lower the Bridge charge.

Ask your prescriber how to submit a Bridge request and ask your plan to confirm your plan type. The Medicare and CMS links below explain the programme. Get a decision for your case before relying on that price.

A cash offer is a separate question

As checked in September 2026, money paid outside insurance does not count towards the plan’s deductible or yearly limit on your own spending. That limit is called the out-of-pocket maximum.

Ask the insurer how it counts your costs. The deductible is the amount you first pay before the plan starts paying under its terms. Ask how much you would still owe through the plan after paying a pharmacy yourself.

Write down both routes if you are comparing them. Ask what each amount covers and what documentation is needed.

Open this chapter’s source notes

This chapter’s reading notes

CMS overview of the Medicare Bridge

CMS is the agency that runs Medicare; this page explains the separate, temporary payment programme.

CMS Bridge criteria and product forms

The prescriber-facing page gives the criteria and the restriction to the Zepbound KwikPen.

Medicare’s reader-facing coverage page

Read this beside the product and criteria details, then ask how the plan would handle your prescription.